{"id":620,"date":"2022-04-25T21:04:36","date_gmt":"2022-04-25T21:04:36","guid":{"rendered":"https:\/\/newsletters.aans.org\/tumor\/?page_id=620"},"modified":"2022-04-26T14:37:53","modified_gmt":"2022-04-26T14:37:53","slug":"cns-tumor-section-2021","status":"publish","type":"page","link":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/","title":{"rendered":"CNS Tumor Section 2021"},"content":{"rendered":"<p>Jon Sherman, Maryam Rahman, Brad Zacharia, Michael Ivan<\/p>\n<p>&nbsp;<\/p>\n<p>The Tumor Section provided a dynamic educational program for the CNS Annual Meeting in Austin, TX Oct 16-20, 2021. The weekend symposia included topics covering malignant and benign brain tumor management, incorporation of advanced techniques such as functional mapping, novel therapeutics including immunotherapy, and also featured 3D neuroanatomy didactics with world renowned faculty. During the week there were several tumor related sunrise sessions, luncheon seminars and afternoon abstract presentations that featured diverse speakers and topics of interest for tumor surgeons including pituitary tumors, low grade gliomas, meningiomas, brain metastases and glioblastoma. Highlights included case-based formats, complications discussions, novel upfront and adjuvant treatment strategies, alternatives to traditional surgery (such as LITT, brachytherapy, CED), quality and efficiency of care, guidelines for primary and metastatic tumors, and complex intracranial approaches. Most importantly, this comprehensive program offered opportunities for tumor section members to highlight their work and to engage learners from diverse backgrounds. We thank of the contributors for their time and effort in making this program a success!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jon Sherman, Maryam Rahman, Brad Zacharia, Michael Ivan &nbsp; The Tumor Section provided a dynamic educational program for the CNS Annual Meeting in Austin, TX Oct 16-20, 2021. The weekend symposia included topics covering malignant and benign brain tumor management, incorporation of advanced techniques such as functional mapping, novel therapeutics including immunotherapy, and also featured [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":596,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-620","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CNS Tumor Section 2021 - Tumor News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CNS Tumor Section 2021 - Tumor News\" \/>\n<meta property=\"og:description\" content=\"Jon Sherman, Maryam Rahman, Brad Zacharia, Michael Ivan &nbsp; The Tumor Section provided a dynamic educational program for the CNS Annual Meeting in Austin, TX Oct 16-20, 2021. The weekend symposia included topics covering malignant and benign brain tumor management, incorporation of advanced techniques such as functional mapping, novel therapeutics including immunotherapy, and also featured [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Tumor News\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-26T14:37:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/cns-tumor-section-2021\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/cns-tumor-section-2021\\\/\",\"name\":\"CNS Tumor Section 2021 - Tumor News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\"},\"datePublished\":\"2022-04-25T21:04:36+00:00\",\"dateModified\":\"2022-04-26T14:37:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/cns-tumor-section-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/cns-tumor-section-2021\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/cns-tumor-section-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tumor News Spring 2022\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-news-spring-2022\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CNS Tumor Section 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"name\":\"Tumor News\",\"description\":\"Just another AANS Newsletter Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\",\"name\":\"Tumor News\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"width\":2336,\"height\":2294,\"caption\":\"Tumor News\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CNS Tumor Section 2021 - Tumor News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/","og_locale":"en_US","og_type":"article","og_title":"CNS Tumor Section 2021 - Tumor News","og_description":"Jon Sherman, Maryam Rahman, Brad Zacharia, Michael Ivan &nbsp; The Tumor Section provided a dynamic educational program for the CNS Annual Meeting in Austin, TX Oct 16-20, 2021. The weekend symposia included topics covering malignant and benign brain tumor management, incorporation of advanced techniques such as functional mapping, novel therapeutics including immunotherapy, and also featured [&hellip;]","og_url":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/","og_site_name":"Tumor News","article_modified_time":"2022-04-26T14:37:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/","url":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/","name":"CNS Tumor Section 2021 - Tumor News","isPartOf":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#website"},"datePublished":"2022-04-25T21:04:36+00:00","dateModified":"2022-04-26T14:37:53+00:00","breadcrumb":{"@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/cns-tumor-section-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/newsletters.aans.org\/tumor\/"},{"@type":"ListItem","position":2,"name":"Tumor News Spring 2022","item":"https:\/\/newsletters.aans.org\/tumor\/tumor-news-spring-2022\/"},{"@type":"ListItem","position":3,"name":"CNS Tumor Section 2021"}]},{"@type":"WebSite","@id":"https:\/\/newsletters.aans.org\/tumor\/#website","url":"https:\/\/newsletters.aans.org\/tumor\/","name":"Tumor News","description":"Just another AANS Newsletter Sites site","publisher":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/newsletters.aans.org\/tumor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/newsletters.aans.org\/tumor\/#organization","name":"Tumor News","url":"https:\/\/newsletters.aans.org\/tumor\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","width":2336,"height":2294,"caption":"Tumor News"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/comments?post=620"}],"version-history":[{"count":3,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/620\/revisions"}],"predecessor-version":[{"id":663,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/620\/revisions\/663"}],"up":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/596"}],"wp:attachment":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/media?parent=620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}